3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
23
Phase NA
14
Phase 1
11
Phase 1/2
8
Phase EARLY_PHASE1
1
Phase 4
1
Phase 3
1
Status
Completed
11
Unknown
4
Terminated
2
Not yet recruiting
2
Active not recruiting
2
Withdrawn
1
Recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other hematologic neoplasm
1
Classical hematology
1
Conditions
Breast Neoplasms
10
Neoplasms
9
Polycystic Ovary Syndrome
8
Infertility
5
Liver Neoplasms
4
Pain, Postoperative
3
Neoplasm Metastasis
3
Multiple Myeloma
3
Lung Neoplasms
3
Head and Neck Neoplasms
3
Carcinoma, Hepatocellular
3
Urinary Bladder Neoplasms
2
Recurrence
2
Pulmonary Embolism
2
Prostatic Neoplasms
2
Pleural Effusion
2
Pancreatic Neoplasms
2
Ovarian Neoplasms
2
Neuroma, Acoustic
2
Melanoma
2
Lymphoma, Follicular
2
Leiomyoma
2
Inflammation
2
Febrile Neutropenia
2
Colorectal Neoplasms
2
Bites and Stings
2
Anovulation
2
Vomiting
1
Venous Thrombosis
1
Venous Thromboembolism
1
Interventions
ceftolozane, tazobactam drug combination
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 4
×
Withdrawn
×
Hematologic Neoplasms
×
Clear all
NCT05061654
2023-08-14
CEF-10
Hamad Medical Corporation
Phase 4
Withdrawn